Endometriosis stromal cells induce bone marrow mesenchymal stem cell differentiation and PD-1 expression through paracrine signaling

article OA: closed CC0 ⤵ 12 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-28

Endometriosis stromal cells induce bone marrow mesenchymal stem cell differentiation and PD-1 expression via paracrine signaling involving the CXCL12/CXCR4 axis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

The study investigated whether endometriosis-derived stromal cells regulate the differentiation of bone marrow-derived cells (BMDCs) that engraft endometriotic lesions, using in-vitro co-culture of BMDCs with stromal cells from endometriosis patients versus control endometrium and in-vivo evaluation in a murine endometriosis model. BMDCs cocultured with endometriosis stromal cells showed increased mRNA and protein levels of stromal, epithelial, and leukocyte markers (vimentin and cytokeratin) and a key immune checkpoint, PD-1, and PD-1 induction in engrafted BMDCs was confirmed in vivo. Inhibition of the CXCR4 receptor with AMD3100 blocked PD-1 expression in BMDCs, implicating CXCL12-dependent paracrine signaling. The paper does not directly measure functional consequences of PD-1 induction for T cell activity within this experimental setup, beyond discussing a plausible immune-tolerance mechanism. This paper is centrally about endometriosis — it shows endometriosis stromal cells promote BMDC differentiation and induce PD-1 via CXCL12/CXCR4 signaling, linking BMDC remodeling to immune evasion in endometriotic lesions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is an estrogen-dependent, inflammatory gynecological disorder characterized by the growth of endometrial cells in lesions outside the uterus. Bone marrow-derived cells (BMDCs) engraft lesions and increase lesion size. Do endometriosis cells regulate differentiation of engrafted BMDCs in the pathogenesis and growth of endometriosis? Here, we report endometriosis derived stromal cells promote the differentiation of BMDCs to stromal, epithelial and leukocyte cell fates through paracrine signaling. In-vitro studies demonstrated that both mRNA and protein levels of vimentin, cytokeratin and PD-1 were significantly increased in BMDCs cocultured with stromal cells from endometriosis (ENDO) patients compared to stromal cells from normal endometrium (CNTL). Increased expression of PD-1 has been reported in malignancy where it promotes T cell quiescence and immune tolerance. Increased PD-1 was also confirmed in-vivo where we showed that PD-1 expression was induced in BMDCs engrafted into endometriotic lesions in a murine model of endometriosis. AMD3100, an antagonist for CXCR4 receptor inhibited PD-1 expression in BMDCs suggesting that PD-1 induction requires CXCL12. These results suggest that endometriosis stimulated BMDC differentiation through paracrine signaling and increased T cell PD-1 expression. Increased PD-1 expression may be one mechanism by which endometriosis avoids immune surveillance.
Full text 15,224 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Endometriosis is an estrogen-dependent, inflammatory gynecological disorder characterized by the growth of endometrial cells in lesions outside the uterus. Bone marrow-derived cells (BMDCs) engraft lesions and increase lesion size. Do endometriosis cells regulate differentiation of engrafted BMDCs in the pathogenesis and growth of endometriosis? Here, we report endometriosis derived stromal cells promote the differentiation of BMDCs to stromal, epithelial and leukocyte cell fates through paracrine signaling. In-vitro studies demonstrated that both mRNA and protein levels of vimentin, cytokeratin and PD-1 were significantly increased in BMDCs cocultured with stromal cells from endometriosis (ENDO) patients compared to stromal cells from normal endometrium (CNTL). Increased expression of PD-1 has been reported in malignancy where it promotes T cell quiescence and immune tolerance. Increased PD-1 was also confirmed in-vivo where we showed that PD-1 expression was induced in BMDCs engrafted into endometriotic lesions in a murine model of endometriosis. AMD3100, an antagonist for CXCR4 receptor inhibited PD-1 expression in BMDCs suggesting that PD-1 induction requires CXCL12. These results suggest that endometriosis stimulated BMDC differentiation through paracrine signaling and increased T cell PD-1 expression. Increased PD-1 expression may be one mechanism by which endometriosis avoids immune surveillance. Similar content being viewed by others

References

Giudice LC (2010) Clinical practice. Endometriosis N Engl J Med 362:2389–2398. https://doi.org/10.1056/NEJMcp1000274 Johnson NP, Hummelshoj L (2013) Consensus on current management of endometriosis. Hum Reprod 28:1552–1568. https://doi.org/10.1093/humrep/det050 Mounsey AL, Wilgus A, Slawson DC (2006) Diagnosis and management of endometriosis. Am Fam Physician 74:594–600 Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM (1984) Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 64:151–154 Tal A, Tal R, Pluchino N, Taylor HS (2019) Endometrial cells contribute to preexisting endometriosis lesions in a mouse model of retrograde menstruationdagger. Biol Reprod 100:1453–1460. https://doi.org/10.1093/biolre/ioz039 Polymeri A, Giannobile WV, Kaigler D (2016) Bone marrow stromal stem cells in tissue engineering and regenerative medicine. Horm Metab Res 48:700–713. https://doi.org/10.1055/s-0042-118458 Pluchino N, Taylor HS (2016) Endometriosis and stem cell trafficking. Reprod Sci 23:1616–1619. https://doi.org/10.1177/1933719116671219 Sakr S, Naqvi H, Komm B, Taylor HS (2014) Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus Whereas Bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment. Endocrinology 155:1489–1497. https://doi.org/10.1210/en.2013-1977 Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344:385–386. https://doi.org/10.1056/nejm200102013440516 Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, Ogawa R, Good RA, Ikehara S (1994) Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 152:3119–3127 Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439–1441. https://doi.org/10.1016/s0140-6736(04)16104-7 Ikehara S (2001) Successful allogeneic bone marrow transplantation. Crucial roles of stromal cells in prevention of graft rejection. Acta Haematol 105:172–178. https://doi.org/10.1159/000046561 Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG (2011) Immune interactions in endometriosis. Expert Rev Clin Immunol 7:611–626. https://doi.org/10.1586/eci.11.53 Agostinis C, Zorzet S, De Leo R, Zauli G, De Seta F, Bulla R (2015) The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis. Mediators Inflamm 2015:918089. https://doi.org/10.1155/2015/918089 Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, Agarwal A (2002) Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17:426–431. https://doi.org/10.1093/humrep/17.2.426 Chen D, Tang P, Liu L, Wang F, Xing H, Sun L, Jiang Z (2018) Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway. Cell Cycle 17:858–867. https://doi.org/10.1080/15384101.2018.1442624 Walankiewicz M, Grywalska E, Polak G, Korona-Glowniak I, Witt E, Surdacka A, Kotarski J, Rolinski J (2018) The increase of circulating PD-1- and PD-L1-expressing lymphocytes in endometriosis: correlation with clinical and laboratory parameters. Mediators Inflamm 2018:7041342. https://doi.org/10.1155/2018/7041342 Sharpe AH, Pauken KE (2018) The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol 18:153–167. https://doi.org/10.1038/nri.2017.108 Chen X, Fosco D, Kline DE, Meng L, Nishi S, Savage PA, Kline J (2014) PD-1 regulates extrathymic regulatory T-cell differentiation. Eur J Immunol 44:2603–2616. https://doi.org/10.1002/eji.201344423 Lim TS, Chew V, Sieow JL, Goh S, Yeong JP, Soon AL, Ricciardi-Castagnoli P (2016) PD-1 expression on dendritic cells suppresses CD8(+) T cell function and antitumor immunity. Oncoimmunology 5:e1085146. https://doi.org/10.1080/2162402x.2015.1085146 McKay JT, Egan RP, Yammani RD, Chen L, Shin T, Yagita H, Haas KM (2015) PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism. J Immunol 194:2289–2299. https://doi.org/10.4049/jimmunol.1401673 Wu L, Lv C, Su Y, Li C, Zhang H, Zhao X, Li M (2019) Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol. Gynecol Endocrinol 35:251–256. https://doi.org/10.1080/09513590.2018.1519787 (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67:817–21. https://doi.org/10.1016/s0015-0282(97)81391-x Ryan IP, Schriock ED, Taylor RN (1994) Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab 78:642–649. https://doi.org/10.1210/jcem.78.3.8126136 Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, Agarwal VR, Zhao Y, Carr BR, Bulun SE (1997) Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 82:600–606. https://doi.org/10.1210/jcem.82.2.3783 Krikun G, Mor G, Alvero A, Guller S, Schatz F, Sapi E, Rahman M, Caze R, Qumsiyeh M, Lockwood CJ (2004) A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 145:2291–2296. https://doi.org/10.1210/en.2003-1606 Barr A, Manning D (1999) G proteins techniques of analysis. CRC Press Inc, Boca Raton, pp 227–245 Tal R, Liu Y, Pluchino N, Shaikh S, Mamillapalli R, Taylor HS (2016) A murine 5-fluorouracil-based submyeloablation model for the study of bone marrow-derived cell trafficking in reproduction. Endocrinology 157:3749–3759. https://doi.org/10.1210/en.2016-1418 Du H, Taylor HS (2007) Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 25:2082–2086. https://doi.org/10.1634/stemcells.2006-0828 Lee B, Du H, Taylor HS (2009) Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod 80:79–85. https://doi.org/10.1095/biolreprod.108.070391 Wang X, Mamillapalli R, Mutlu L, Du H, Taylor HS (2015) Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression. Stem Cell Res 15:14–22. https://doi.org/10.1016/j.scr.2015.04.004 Zhang WB, Cheng MJ, Huang YT, Jiang W, Cong Q, Zheng YF, Xu CJ (2012) A study in vitro on differentiation of bone marrow mesenchymal stem cells into endometrial epithelial cells in mice. Eur J Obstet Gynecol Reprod Biol 160:185–190. https://doi.org/10.1016/j.ejogrb.2011.10.012 Morelli SS, Rameshwar P, Goldsmith LT (2013) Experimental evidence for bone marrow as a source of nonhematopoietic endometrial stromal and epithelial compartment cells in a murine model. Biol Reprod 89:7. https://doi.org/10.1095/biolreprod.113.107987 Yin M, Zhou HJ, Lin C, Long L, Yang X, Zhang H, Taylor H, Min W (2019) CD34(+)KLF4(+) stromal stem cells contribute to endometrial regeneration and repair. Cell Rep 27:2709-2724.e3. https://doi.org/10.1016/j.celrep.2019.04.088 Moridi I, Mamillapalli R, Cosar E, Ersoy GS, Taylor HS (2016) Bone marrow stem cell chemotactic activity is induced by elevated CXCl12 in endometriosis. Reprod Sci. https://doi.org/10.1177/1933719116672587 Pluchino N, Mamillapalli R, Shaikh S, Habata S, Tal A, Gaye M, Taylor HS (2020) CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking. J Cell Mol Med 24:2464–2474. https://doi.org/10.1111/jcmm.14933 Du H, Naqvi H, Taylor HS (2012) Ischemia/reperfusion injury promotes and granulocyte-colony stimulating factor inhibits migration of bone marrow-derived stem cells to endometrium. Stem Cells Dev 21:3324–3331. https://doi.org/10.1089/scd.2011.0193 Tal R, Shaikh S, Pallavi P, Tal A, Lopez-Giraldez F, Lyu F, Fang YY, Chinchanikar S, Liu Y, Kliman HJ, Alderman M 3rd, Pluchino N, Kayani J, Mamillapalli R, Krause DS, Taylor HS (2019) Adult bone marrow progenitors become decidual cells and contribute to embryo implantation and pregnancy. PLoS Biol 17:e3000421. https://doi.org/10.1371/journal.pbio.3000421 Taylor HS (2004) Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 292:81–85. https://doi.org/10.1001/jama.292.1.81 Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, Cancedda R, Pennesi G (2005) Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35:1482–1490. https://doi.org/10.1002/eji.200425405 Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL (2005) CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 25:9543–9553. https://doi.org/10.1128/mcb.25.21.9543-9553.2005 Nematian SE, Mamillapalli R, Kadakia TS, Majidi Zolbin M, Moustafa S, Taylor HS (2018) Systemic inflammation induced by microRNAs: endometriosis-derived alterations in circulating microRNA 125b–5p and Let-7b-5p regulate macrophage cytokine production. J Clin Endocrinol Metab 103:64–74. https://doi.org/10.1210/jc.2017-01199 Bellelis P, Barbeiro DF, Rizzo LV, Baracat EC, Abrao MS, Podgaec S (2013) Transcriptional changes in the expression of chemokines related to natural killer and T-regulatory cells in patients with deep infiltrative endometriosis. Fertil Steril 99:1987–1993. https://doi.org/10.1016/j.fertnstert.2013.02.038 Kitaya K, Nakayama T, Daikoku N, Fushiki S, Honjo H (2004) Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium. J Clin Endocrinol Metab 89:2470–2476. https://doi.org/10.1210/jc.2003-031293 Leconte M, Chouzenoux S, Nicco C, Chereau C, Arkwright S, Santulli P, Weill B, Chapron C, Dousset B, Batteux F (2014) Role of the CXCL12-CXCR4 axis in the development of deep rectal endometriosis. J Reprod Immunol 103:45–52. https://doi.org/10.1016/j.jri.2013.12.121 Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184:1101–1109. https://doi.org/10.1084/jem.184.3.1101 Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA (2001) Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97:3354–3360. https://doi.org/10.1182/blood.v97.11.3354 Cheng JW, Sadeghi Z, Levine AD, Penn MS, von Recum HA, Caplan AI, Hijaz A (2014) The role of CXCL12 and CCL7 chemokines in immune regulation, embryonic development, and tissue regeneration. Cytokine 69:277–283. https://doi.org/10.1016/j.cyto.2014.06.007 Kim CH, Broxmeyer HE (1998) In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91:100–110

Acknowledgements

We thank Aya Tal for anti-CD3 staining and Marie Gaye for proofreading the manuscript. Funding This work was supported by the Endometriosis Foundation of America AWD0003567. Author information Authors and Affiliations Contributions PC performed experiments, analyzed the data and drafted the manuscript. RM designed the study, study implementation, analyzed the data, prepared the figures, drafted and revised the manuscript. SH participated in the experiments and read the manuscript. HT conceived, design study, analyzed the data and finalized the manuscript. Corresponding author Ethics declarations Conflict of interest The authors declare that they have no conflict of interest. Consent for publication All authors have read the manuscript and authorized the submission for publication. Ethical approval All procedures performed in this study involving patients and animals were in accordance with the ethical standards of the Ethical Committee of Yale University. Appropriate guidelines have been followed for the use of animals. Written informed consent was signed by all patients. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Electronic supplementary material Below is the link to the electronic supplementary material. Suppl Fig. 1 (download PDF ) Immunostaining of lesions showing T-cells. Representative image of lesion section showing CD3 expression, a marker for T-cells. Murine lesions were stained with anti-CD3 antibody (brown). Scale bar: 100 μm. (PDF 713 kb) Suppl. Fig. 2 (download TIF ) Gross morphology of endometriotic lesions: Circles (yellow) indicate endometriotic lesions (left). H & E staining of lesion tissue section showing glandular uterine structure (right). (TIF 630 kb) Rights and permissions About this article Cite this article Chen, P., Mamillapalli, R., Habata, S. et al. Endometriosis stromal cells induce bone marrow mesenchymal stem cell differentiation and PD-1 expression through paracrine signaling. Mol Cell Biochem 476, 1717–1727 (2021). https://doi.org/10.1007/s11010-020-04012-1 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s11010-020-04012-1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Bone Marrow Cells Cell Differentiation Endometriosis Gene Expression Regulation Mesenchymal Stem Cells Paracrine Communication Programmed Cell Death 1 Receptor Adolescent Adult Bone Marrow Cells Bone Marrow Cells Coculture Techniques Endometriosis Endometriosis Female Humans Mesenchymal Stem Cells Middle Aged Programmed Cell Death 1 Receptor Stromal Cells

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (50)

Cited by (12)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:25:00.839251+00:00
License: CC0 · commercial use OK